Diaceutics PLC Financial Flexibility Index
Diaceutics PLC financial flexibility index. Diaceutics PLC (DXRX) has a Financial Flexibility Index of 0.07x as of December 2025. Free cash flow of GBX712.00K (operating CF GBX696.00K minus capex GBX16.00K) represents 0% of total liabilities (GBX9.53 Million). Explore DXRX capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Diaceutics PLC (2016–2025)
Financial flexibility index of Diaceutics PLC from 2016 to 2025. Historical Financial Flexibility Index trend for Diaceutics PLC across 10 annual periods. Check Diaceutics PLC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Diaceutics PLC Financial Flexibility Index by Year (2016–2025)
Diaceutics PLC financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for Diaceutics PLC. For the full cash flow conversion analysis, see DXRX cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.16x | GBX1.57 Million | GBX1.50 Million | GBX9.53 Million | ▼ -72.7% |
| 2024 | 0.60x | GBX5.28 Million | GBX651.00K | GBX8.76 Million | ▼ -45.7% |
| 2023 | 1.11x | GBX6.17 Million | GBX1.31 Million | GBX5.56 Million | ▼ -36.1% |
| 2022 | 1.74x | GBX9.97 Million | GBX5.10 Million | GBX5.74 Million | ▲ +22.7% |
| 2021 | 1.41x | GBX6.17 Million | GBX570.00K | GBX4.36 Million | ▼ -29.1% |
| 2020 | 2.00x | GBX6.55 Million | GBX253.00K | GBX3.28 Million | ▲ +94.3% |
| 2019 | 1.03x | GBX2.30 Million | GBX-627.05K | GBX2.24 Million | ▲ +3364.8% |
| 2018 | 0.03x | GBX153.59K | GBX-954.04K | GBX5.18 Million | ▼ -94.1% |
| 2017 | 0.50x | GBX1.82 Million | GBX1.53 Million | GBX3.61 Million | ▲ +73.7% |
| 2016 | 0.29x | GBX703.05K | GBX674.01K | GBX2.43 Million | — |